chrisvoncsefalvay/vaers-outcomes huggingface dataset:
14JAN98 feeling tired, cold pale;15JAN98 fever 103.6 not controlled by APAP;tired, dyspnea, sore throat, stomachache, fatigue;taken to ER dx w/walking pneumonia, loss of appetite;later cough & wheezing;
was told that it was infected; Started itching below the injection site; lymph node under her arm that is sore and swollen; arm was red and swollen below the injection site; arm was red and swollen below the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INFECTION (was told that it was infected), VACCINATION SITE PRURITUS (Started itching below the injection site), VACCINATION SITE LYMPHADENOPATHY (lymph node under her arm that is sore and swollen), VACCINATION SITE SWELLING (arm was red and swollen below the injection site) and VACCINATION SITE ERYTHEMA (arm was red and swollen below the injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Prozac allergy) and Drug allergy (Wellburtin allergy). Concomitant products included LORATADINE for Allergy, LISINOPRIL for Blood pressure high, ESTRADIOL and MEDROXYPROGESTERONE for Hormone therapy, CLONAZEPAM for Nerve pain.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFECTION (was told that it was infected), VACCINATION SITE PRURITUS (Started itching below the injection site), VACCINATION SITE LYMPHADENOPATHY (lymph node under her arm that is sore and swollen), VACCINATION SITE SWELLING (arm was red and swollen below the injection site) and VACCINATION SITE ERYTHEMA (arm was red and swollen below the injection site). At the time of the report, VACCINATION SITE INFECTION (was told that it was infected), VACCINATION SITE PRURITUS (Started itching below the injection site), VACCINATION SITE LYMPHADENOPATHY (lymph node under her arm that is sore and swollen), VACCINATION SITE SWELLING (arm was red and swollen below the injection site) and VACCINATION SITE ERYTHEMA (arm was red and swollen below the injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was prescribed Cephalexin 500mg, Atarax 10mg , Diflucan (Fluconazole)150mg, but she has not taken any of these yet.   This case was linked to MOD-2021-017024 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up document was received. Patient's demography, relevant medical history and concomitant medications were updated. It contains significant information.
A week after second shot i had a fever off and on , no appetite, also felt like I couldn?t breath at one point and started hyperventilating?about four days later I had brown spotting , then intense cramping PMS symptoms for 2 weeks straight , I was also 16 days late on my period. When receiving my period it was 7 days as it normally is and was fine after period ended I am now having chest pains on the left side .
very sick; Initial information was received on 10-Oct-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional via social media.  This case involves a patient (age and gender unspecified) who had very sick (illness), after patient received INFLUENZA VACCINE (MONOVALENT) (swine flu vaccine).  Medical history, medical treatment, vaccination, family history and concomitant medication were not reported.  On an unknown date (year ago), the patient received a dose of suspect INFLUENZA VACCINE (MONOVALENT) (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, the patient got very sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE (MONOVALENT).  Additionally, it was reported that, patient did not get one for years after that.  Details of laboratory data not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported for illness.   There will be no information available on the batch number for this case.
severe muscular & joint pain & incapacitating fatigue;any movements caused pain;dec ROM hips & shoulders;
Moderna COVID-19 vaccine EUA - flu like symptoms, fever, chills, hot, body aches, headache, fatigue, very tired, sore around vaccine site, achiness in the entire arm of the vaccine.  Aspirin and ibuprofen and rest.   Felt the onset about 8 hours after the vaccine, felt bad all day the following day, felt good the next day.
Patient (passenger) was registered for Pfizer booster and was in the same car as her husband (driver) who was registered for Moderna. They were sent to the Moderna lane and were correctly checked in for their respective boosters. However, the vaccinator administered the Moderna booster for both patients instead of the Pfizer booster for the passenger. Nurse informed her lead and pharmacist of the error. Patient was informed of the error by the pharmacist and addressed all her questions & concerns.
Dose administered >12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered >12 hours post puncture) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017f21a) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered >12 hours post puncture). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered >12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported   No treatment information was provided
Dizziness; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 02Feb2021 10:30 as 2nd dose, single for COVID-19 immunization. Medical history included breast cancer from an unknown date and unknown if ongoing. The patient has no history of covid prior vaccination and was not covid tested post vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date, for COVID-19 immunization. The patient experienced dizziness worsening daily and fatigue on 08Feb2021 with outcome of not recovered. The events resulted in a doctor or other healthcare professional office/clinic visit. No treatment was received for the events.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.
Tiredness Muscle Pain Headache Shivering fever Stiff Neck Weak Dizzy Hot to touch
very severe arm pain; she feel like truck went over her; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very severe arm pain), FEELING ABNORMAL (she feel like truck went over her) and PAIN (body ache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (very severe arm pain), FEELING ABNORMAL (she feel like truck went over her) and PAIN (body ache). At the time of the report, PAIN IN EXTREMITY (very severe arm pain), FEELING ABNORMAL (she feel like truck went over her) and PAIN (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Pt was give flu vaccine in error it was pt 3 years of age and older pt was observed for 1 hour no reaction noted. Called to f/u next day and mother states the patient feel warm to touch. Pt brought into clinic for nurse visit to check if baby had fever.
The day after patient received the vaccine, she had severe headache. She was sent to ER on 11/07/2021 .Culture was drawn and she was discharged home. On 11/09/2021, hospital notified patient that she had bacterial meningitis.
PRODUCT WAS EXPOSED TO A TEMPERATURE OF 35.15 DEGREE FAHRENHEIT FOR 30 MINUTES; ADMINISTRATION OF A DOSE FROM A VIAL THAT WAS STORED OUTSIDE THE RECOMMENDED STORAGE CONDITION; This spontaneous report received from a physician concerned a 50 year old female. The patient's height, and weight were not reported. The patient's past medical history included: fatigue, and fibromyalgia, and concurrent conditions included: non-smoker, and other pre-existing medical conditions included: The patient had no known allergies and was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, administered on 16-MAY-2022 for prophylactic vaccination. The drug was associated with Medication error. No concomitant medications were reported.  On 16-MAY-2022, the patient experienced administration of a dose from a vial that was stored outside the recommended storage condition. On an unspecified date, the patient experienced product was exposed to a temperature of 35.15 degree fahrenheit for 30 minutes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of a dose from a vial that was stored outside the recommended storage condition and product was exposed to a temperature of 35.15 degree fahrenheit for 30 minutes was not reported. This report was non-serious.
Did not refrigerate the Vivotif capsules and administered all the incorrectly stored doses; A spontaneous report was received from a nurse on 09NOV2022. It described a 36-year-old female patient who "did not refrigerate the Vivotif capsules and administered all the incorrectly stored doses" (PT: Product storage error). The patient took the Vivotif (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient did not refrigerate the Vivotif capsules and administered all the incorrectly stored doses as per the dosage regimen. Reportedly, the patient completed her regimen in the first week of NOV2022 and did not experience any side effects. Additionally, it was reported that the patient would be traveling on 11NOV2022. The outcome of the reported event was not applicable.  Action taken with Vivotif with respect to the reported event was not applicable.  No additional information was reported.  Company comment: It was reported that a consumer did not refrigerate the Vivotif capsules and administered all the incorrectly stored doses (product storage error). Vivotif should always be stored in the refrigerator at the recommended temperature, and the causality of product storage error is assessed as not applicable to Vivotif due to the nature of the event which was due to human error. The case is considered non-serious as per medical assessment.; Sender's Comments: It was reported that a consumer did not refrigerate the Vivotif capsules and administered all the incorrectly stored doses (product storage error). Vivotif should always be stored in the refrigerator at the recommended temperature, and the causality of product storage error is assessed as not applicable to Vivotif due to the nature of the event which was due to human error. The case is considered non-serious as per medical assessment.
Well the next day I felt like I couldn't breath and I was very pail and cold and clammy. The people that I live with told me I passed out for about 30 seconds. I had that tingly feeling all over my body and could not breath still. They called the ambulance and went to the hospital, they gave me Ativan, but they told me I needed to see a DR and get checked out. So after I left the hospital I was fine but every day since the 11th on June 2021 I have had similar symptoms but just a little smaller intensity. Eventually the shortness of breath it started to go away. Then on the 19th of June I was very light headed and just feeling very week for about 4 hours and then on Monday the 21st of June I had a "normal" day so apparently I am starting to feel better. On the 15th of June I also had a very bad heavy breathing panic attack like symptoms. She prescribed me the generic of Ativan. I went to the DR yesterday 6/22/2021 to follow up, but am feeling better so far. I have felt fine ever since the 21st June 2021, but that has been only a few days since then.
An hour or two after getting the FIRST Pfizer vaccine, my kids noticed my palms were bright red. The veins in my fingers, palms and wrists looked swollen too.  Today, I looked at a recipe I copied off the internet a few hours after the vaccination. I misspelled 6 words. (The word cup was misspelled "cub" and "cube", the word tablespoon was "tblsoops", chill was "chil", etc.) This is not normal for me.  The next day, my palms were no longer red and the veins were back to normal. I did have any other reactions.  I suspect our family had covid last March because my husband and I had symptoms that would later be added to the list. (loss of taste, digestive issues, dizziness, heart racing in addition to sore throat, body aches, breathing difficulty) My husband and I were sick for about 3 weeks then 3 weeks recovering. Our kids had a sore throat for 2-3 days only.
Swollen face, arms, legs within hours of vaccination. Next morning eyes swelled shut, swollen tongue and lips, caused trip to ER. Instructed to give Benadryl & not have booster. Child vomiting by that evening. 48 hrs later, rash all over body (not pox). Never had reaction from other routine vacs other than cranky.
Site: Redness at Injection Site-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Additional Details: PATIENT FELT TIGHTNESS ON HIS THROAT AND WE CALLED EMERGENCY THEN HE SAID HE IS FINE & TO CANCEL IT. AFTER ABOUT 15MINS HE FELT TIGHTNESS ON HIS THROAT AGAIN WE WE CALLED EMERGENCY. PARAMEDICS CAME CHECKED HIS VITALS EVERYTHING WAS NORMAL. HE WAS VERY ANXIOUS/NERVOUS ABOUT VACCINE. HE FELT MUCH BETTER AFTER A WHILE. HE WALKED OUT WITH THE PARAMEDICS BUT NOT SURE HE IS WENT TO ER OR NOT...
102.9 fever, muscle joint body aches for 30 hours,  Fever broke, now back at 100.4.  Aches persistent.
Information has been received from a pharmacist (from a drug information center) concerning a male patient who received approximately on 19-APR-2009 a dose of ZOSTAVAX (Merck) (dose, route and lot number not specified). It was reported that the patient was prescribed AUGMENTIN after vaccination. The pharmacist reported it was not known why the patient was taking AUGMENTIN but the pharmacist did not believe it was directly related to the injection. The outcome of the patient was unknown. The patient sought unspecified medical attention. Additional information has been requested.
This spontaneous report was received from a nurse practitioner refers to a 18 years old patient who on 29-AUG-2012, was vaccinated subcutaneously with a dose of M-M-R II subcutaneously (Lot number: 0234AE, expiry date: 26-JAN-2014, Lot number: 1003AA, expiry date: 28-JUN-2013) that was stored at 47 Fahrenheit for 13 hours. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
weird taste in mouth; like a burnt oatmeal taste; Nausea; This is a spontaneous report from a contactable nurse. A 60-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL1283, expiry date not reported), intramuscular on 09Jan2021 12:00 at a single dose in the left arm for COVID-19 immunization. Medical history included had known allergies to sulfa and patient had the COVID virus back in Oct2020 to an unknown date. The patient was not pregnant at the time of vaccination. Concomitant medication included celecoxib (CELEBREX). The patient had the first dose of BNT162B2 on an unknown date for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in the hospital. Patient wanted to report a side effect and was reading a little about it. She had her second dose of the Pfizer Covid-19 vaccine last Saturday, 09Jan2021 and has like a weird taste in her mouth on 11Jan2021. It's like a burnt oatmeal taste. Patient wanted to know if anyone has ever reported that. Patient reported nausea with weird taste in my mouth, not a loss of taste but taste of burnt oatmeal. Patient had the COVID virus back in Oct2020 and she didn't have taste or smell at all then and now she has a taste so it's not like she has COVID again. No treatments received in related to the events reported. Since the vaccination, the patient has not been tested for COVID19.  The outcome of the events "weird taste in mouth; like a burnt oatmeal taste" and nausea was not recovered.  Information on the batch/lot has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021025273 Pfizer
2/22/21- Husband reported redness to injection site. Took to ER 2/23/21- Husband reported patient was admitted as inpatient for cellulitis and will be kept in hospital for IV antibiotics until 2/25/21 or 2/26/2021
This patient's mother noticed a rash on his legs on 02/06/01. The mother brought the patient in the clinic on 02/07/01 and the doctor prescribed Atarax on 02/07/01.
COVID like symptoms; Lethargic; Extremely dehydrated; Fever; chills; Dizzy; felt weak; muscle twitches; Had a lot of mucus in throat/ mucus lingers.; making it difficult to breath; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (COVID like symptoms), LETHARGY (Lethargic), DEHYDRATION (Extremely dehydrated), DIZZINESS (Dizzy) and ASTHENIA (felt weak) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (spent 16 days in quarantine) in March 2020. Concomitant products included TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for an unknown indication.    On 12-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Nov-2021, the patient experienced SUSPECTED COVID-19 (COVID like symptoms), LETHARGY (Lethargic), DEHYDRATION (Extremely dehydrated), PYREXIA (Fever) and CHILLS (chills). In November 2021, the patient experienced DIZZINESS (Dizzy), ASTHENIA (felt weak), MUSCLE TWITCHING (muscle twitches), SECRETION DISCHARGE (Had a lot of mucus in throat/ mucus lingers.) and DYSPNOEA (making it difficult to breath). At the time of the report, SUSPECTED COVID-19 (COVID like symptoms), LETHARGY (Lethargic), DEHYDRATION (Extremely dehydrated), DIZZINESS (Dizzy), ASTHENIA (felt weak), MUSCLE TWITCHING (muscle twitches), SECRETION DISCHARGE (Had a lot of mucus in throat/ mucus lingers.), DYSPNOEA (making it difficult to breath), PYREXIA (Fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Company Comment- This spontaneous case concerns a 56-year-old male patient with relevant medical history of COVID-19, who experienced non-serious unexpected event of special interest (AESI) suspected COVID-19. The event occurred one day from the first dose of the Moderna COVID-19 Vaccine (mRNA-1273). Rechallenge was not applicable since due to unknown outcome and lack of information on the second dose, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of drug is not affected by this report.  Patient was taking 50,000 units of vitamin E weekly prior to taking the vaccine and was on that dose while the patient received the vaccine.  No treatment information was reported.; Sender's Comments: This spontaneous case concerns a 56-year-old male patient with relevant medical history of COVID-19, who experienced non-serious unexpected event of special interest (AESI) suspected COVID-19. The event occurred one day from the first dose of the Moderna COVID-19 Vaccine (mRNA-1273). Rechallenge was not applicable since due to unknown outcome and lack of information on the second dose, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of drug is not affected by this report.
This spontaneous report was received from a registered nurse and refers to multiple patients of unspecified age and gender. No information regarding the patients' medical history, concurrent conditions, drug reactions or allergies was reported. On an unspecified dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 (lot#K007826, expiration date: 03-FEB-2016; dose, route of administration and anatomical location were not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
received vaccine on 29Oct2021 with an expiration date of 11Oct2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received vaccine on 29Oct2021 with an expiration date of 11Oct2021) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received vaccine on 29Oct2021 with an expiration date of 11Oct2021). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (received vaccine on 29Oct2021 with an expiration date of 11Oct2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Information has been received from a registered nurse refers to an unknown number of patients of unknown age and gender. On unknown dates, 20 dose of improperly stored PROQUAD (Merck) (lot number, dose and frequency were unknown) were administered to the patients. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information is not expected because the reporter did not want to be contacted.
Mom rpts that pt cried uncontrollably for a day & a half /p recving immun.Mom states the pt had a high pitched screaming crying & she was unable to soothe pt.Mom did not take pt to MD.No other neurological sx reported.